Clearside biomedical, inc. (CLSD)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15Jun'15
License and other revenue

6,225

2,173

0

0

0

-

-

-

-

-

0

0

-

-

-

-

-

-

-

License and collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

0

Operating expenses:
Research and development

8,502

15,658

31,839

49,194

65,879

68,291

64,740

60,707

54,842

49,053

42,089

29,721

22,456

19,455

14,793

13,258

0

0

0

General and administrative

15,557

16,819

17,345

17,437

15,994

14,684

12,949

11,374

10,103

9,700

9,650

8,981

7,661

6,263

4,937

6,331

0

0

0

Total operating expenses

24,059

32,477

49,184

66,631

81,873

82,975

77,689

72,081

64,945

58,753

51,739

38,702

30,117

25,718

19,730

19,589

0

0

0

Loss from operations

-17,834

-30,304

-48,923

-66,511

-81,798

-82,945

-77,634

-71,871

-64,605

-58,408

-51,444

-38,557

-30,097

-25,198

-19,215

-19,079

0

0

0

Other expense

-443

-466

-389

-137

183

127

-39

-266

-604

-567

-724

-920

-709

-684

-456

-184

0

0

0

Net loss

-18,277

-30,770

-49,312

-66,648

-81,615

-82,818

-77,673

-72,137

-65,209

-58,975

-52,168

-39,477

-30,806

-25,882

-19,671

-19,263

0

0

0

Net loss per share of common stock — basic and diluted

-0.07

-0.04

-0.17

-0.15

-0.45

-0.67

-0.75

-0.65

-0.62

-0.66

-0.72

-0.54

-0.41

0.98

-0.28

-0.62

-2.05

-1.31

-2.36

Weighted average shares outstanding — basic and diluted

44,753

42,488

38,414

37,636

34,144

32,112

32,024

31,979

26,818

25,347

25,338

25,309

25,250

21,046

20,493

8,243

2,660

2,651

2,216

Net loss

-18,277

-30,770

-49,312

-66,648

-81,615

-82,818

-77,673

-72,137

-65,209

-58,975

-52,168

-39,477

-30,806

-25,882

-19,671

-19,263

0

0

0

Unrealized gain on available-for-sale investments

-

-

-

-

-

-

-

-

-

5

0

0

0

-

0

-

-

-

-

Comprehensive loss

-

-

-

-

-

-

-

-

-

-58,970

-52,171

-39,500

-30,827

-25,895

-19,676

0

0

0

-